Steven
Brill's Bitter Pill: Why Medical Bills Are Killing Us brings to light the medical complex's drawstrings
that bids medical cost in an ever-increasing part of the national GDP, now
headed toward 20%. It is the
convolutional yoke, in part, strangling our national economy. Brill, the
founder of Court TV, seems to pull no punches, squarely putting blame where it
falls. (His introductory video to the article should be found at the bottom of
first page.)
If you've
looked at a hospital bill (hope you haven't had one), did you understand it,
all the little high priced itemizations? Being indecipherable, most people
instantly glance to the bottom line, the thousands of dollars on the
"Total Due" line. Surprised or not, what other things in life can you
think of that you buy without knowing beforehand what the cost will be?
Brill,
through the documentation of the many real-life medical bill cases he tracked,
helps us understand why medical cost is so high and growing. You can quickly grasp
the possibility of an estimated 700,000 people in the U. S. becoming medically
bankrupted annually, per a study Harvard Law and Harvard Medical School did. You'll
learn how MD Anderson Cancer Center, a nonprofit hospital, makes millions of
dollars annually with a 26% profit margin, net profits many large corporations
envy. And should I say, would be considered profits to die for? And that's
after the CEO and top administrators collect salaries in the millions.
Even though hospital administrators lament that they
can't make it on Medicare payment schedules, in many cases it is their
sustaining revenue. (Even though Brill doesn't give examples of a financially
besieged hospital, no doubt there are those smaller communities which hospitals
struggle to keep above deficit line. And here is where some of my respected
hospital-associated friends might take exception.) Brill says, "By law, Medicare’s payments approximate a hospital’s
cost of providing a service, including overhead, equipment and salaries."
But hospitals have something called the
"Chargemaster," a grossly inflated pricing schedule. It's kind of
what some of us in business used to call "premium billing," you pay
on time you get significant discount. However, with the Chargemaster schedule
--- premium billing takes on a totally different meaning. It's used to
exorbitantly price every "little and big item" from your Tylenol pill
- to room and the cat-scan equipment rendering your test.
From the Chargemaster schedule, Medicare, Medicaid,
and Insured customers get whopping discounts, either by law or in the case of
the medically insured their commercial carrier, such as Aetna, negotiates a much
lower price. Those caught without medical coverage, a young person dropped from
a parents policy, those who can't afford COBRA at loss of employment, those in poverty,
or the insured person whose bill runs over limits of coverage, have to deal
with the Chargemaster, generally without an advocate to reduce the price. They
are left in an insurmountable financial pit, which many times results in
bankruptcy.
Another important point Brill makes is that technology
and the lack of competitive market forces have not reduced the cost of
expensive medical equipment. Comparatively, most all of the technological improvements
for such as TVs, computers, and other appliance over the last several years
have decreased in price.
Brill, determines that doctors are not the recipient
of excessive profits, nor are insurance companies necessarily a part of the
problem. He references our local Spanish owned Grifols plant in Clayton, North
Carolina, where human plasma
is used to make Flebogamma, a sterilized solution that is intended to boost the
immune system. He says, "In Spain, as in the rest of the developed world,
Grifols’ profit margins on sales are much lower than they are in the U.S.,
where it can charge much higher prices. Aware of the leverage that drug
companies — especially those with unique lifesaving products — have on the
market, most developed countries regulate what drugmakers can charge, limiting
them to certain profit margins. In fact, the drugmakers’ securities filings
repeatedly warn investors of tighter price controls that could threaten their
high margins — though not in the U.S."
Brill ends with suggested solutions, such as taxing
75% on the amount over $750,000 that CEOs of nonprofit hospitals make. But he has
little hope that the industrial medical complex's economic-debilitating forces have
a chance for corrections needed. Now with the ACA Framework in place, our
congress has an opportunity to work together to do the right things in amending
and tweaking that framework to improve all it merits, including the essential
cost control elements. You think they can do that? Yes, I do, but only with the
mind's-eye fixed on ethical behavior,
unrestrained of the industrial medical complex's stronghold.
It's a long article, size of a short book, 59 full
pages on attached document, but worthy of your time. Read from the Time's link
or as attached herewith. (The highlights and border block-offs are all mine.)